Terumo has acquired GADA Turkey, an exclusive supplier and distributor of blood bank components and equipment to Turkish public and private healthcare facilities. The company has been a Terumo distributor to blood banks and hospitals since 2009. The acquisition provides Terumo with a direct relationship with Turkish blood banks and the ability to drive further adoption of blood transfusion technologies. The acquisition will also enable hospitals to have expanded access to Terumo therapeutic aphaeresis technologies. GADA Turkey is active in two major segments: blood technologies and general hospital. The blood technologies segment is composed of three different areas: blood banking, transfusion and therapeutics. The general hospital segment focuses on a wide-choice supply of high technology single-use devices and disposables.
Prior to the acquisition, GADA Turkey was a subsidiary of The GADA Group Holding, a UK-based, pan-European, distributor of specialised medical technology devices and equipment and a provider of healthcare services supplies and integrated project to public and private facilities. The transaction has been structured as a share purchase and is expected to close in Terumo's Q414 (ended March 31 2014), subject to approval and customary conditions. After the closing, GADA Turkey will be operated as a subsidiary of Terumo Europe.